ER/PR(+), Her2(-) Breast Cancer
2 clinical trials · Condition
◉ Watch ER/PR(+), Her2(-) Breast Cancer
| Record | Firm | Date |
|---|---|---|
| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (NCT04585750) | PMV Pharmaceuticals, Inc | 2020-10-29 |
| Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan (NCT02924584) | Pfizer | 2017-02-01 |
Track ER/PR(+), Her2(-) Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.